𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Manufacturing and PEGylation of a Dual-Acting Peptide for Diabetes

✍ Scribed by Jochen Krüger; Torsten Minuth; Werner Schröder; Jörn Werwath

Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
363 KB
Volume
2008
Category
Article
ISSN
1434-193X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

[14C] and [3H]-labelling of Ragaglitazar
[14C] and [3H]-labelling of Ragaglitazar: A dual acting PPARα and PPARγ agonist with hypolipidemic and anti-diabetic activity
✍ Jesper B. Kristensen; Steen K. Johansen; Jacob S. Valsborg; Lars Martiny; Christ 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 138 KB

## Abstract Currently, Ragaglitazar is being developed as a drug for the treatment of hyperglycaemia and hyperlipidemia in patients with type 2 diabetes. Here, we report the labelling of Ragaglitazar with carbon‐14 and tritium for in vivo and in vitro investigations. Two different carbon‐14 labelle